Literature DB >> 8694202

The influence of volume therapy and pentoxifylline infusion on circulating adhesion molecules in trauma patients.

J Boldt1, M Heesen, W Padberg, K Martin, G Hempelmann.   

Abstract

Adhesion molecules appear to play a pivotal role in tissue damage secondary to the inflammatory process. Besides neutrophil- and endothelial-bound adhesion molecules, soluble forms have been detected in the circulating blood. They seem to be good markers of endothelial damage, but they may also have other biological functions. Plasma concentrations of soluble adhesion molecules (endothelial leucocyte adhesion molecules (sELAM-1), intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1), and granule membrane protein 140 (sGMP-140) were serially measured over 5 days by enzyme-linked immunosorbent assays (ELISA) in 45 consecutive trauma patients. These received, by random allocation, only either hydroxyethylstarch solution 10% (mean molecular weight 200,000 daltons) (n = 15) or human albumin 20% (n = 15) for volume therapy. Another 15 patients without defined volume therapy received pentoxifylline continuously (1.2 mg.kg-1.h-1). Measurements were carried out on the day of admission to the intensive care unit (baseline) and during the next 5 days. At baseline, plasma concentrations of all adhesion molecules were similar in all groups. In the hydroxyethyl starch group, sELAM-1 and sICAM-1 concentrations decreased significantly (p < 0.05) reaching normal values during the study period whereas the mean (SD) values increased in the pentoxifylline group (sELAM-1: 71.1 (16.7) to 91.6 (17.8) ng.ml-1) and the albumin group (sICAM-1: 400 (81) to 749 (101) ng.ml-1) (p < 0.05). sVCAM-1 increased outside the normal range only in the human albumin group (to 760 +/- 69 ng.ml-1) (p < 0.05). sGMP-140 plasma concentration increased only in those receiving albumin (432 (85) to 550 (93) ng.ml-1) and this was significantly different to the other groups (p < 0.05). None of the other haemodynamic or laboratory factors could be correlated with plasma concentrations of the adhesion molecules. We conclude that volume therapy with hydroxyethyl starch resulted in a decrease in circulating adhesion molecules in our trauma patients. In contrast, volume therapy with albumin did not exert this effect. Continuous infusion of pentoxifylline did not have a beneficial modulating action on circulating adhesion molecules.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694202     DOI: 10.1111/j.1365-2044.1996.tb12557.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  5 in total

1.  Fluid resuscitation in prehospital trauma care: a consensus view.

Authors:  M Revell; K Porter; I Greaves
Journal:  Emerg Med J       Date:  2002-11       Impact factor: 2.740

Review 2.  Colloid solutions for fluid resuscitation.

Authors:  Frances Bunn; Daksha Trivedi
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

3.  Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: systematic review and meta-analysis of randomized trials: ATTENTION: The analysis and conclusions of this article are being revised by the authors. This is due to the journal Anesthesia and Analgesia's retraction of a paper by Dr. Joachim Boldt, an author in seven of the studies analyzed in this review. As such, the editors of Open Medicine recommend interpreting this review with extreme caution until Zarychanski et al. publish a new analysis and interpretation in Open Medicine. For more information, see Anesthesia and Analgesia's press release.

Authors:  Ryan Zarychanski; Alexis F Turgeon; Dean A Fergusson; Deborah J Cook; Paul Hébert; Sean M Bagshaw; Danny Monsour; Lauralyn McIntyre
Journal:  Open Med       Date:  2009-10-27

Review 4.  Salt of the earth or a drop in the ocean? A pathophysiological approach to fluid resuscitation.

Authors:  P Gosling
Journal:  Emerg Med J       Date:  2003-07       Impact factor: 2.740

5.  Pentoxifylline decreases serum level of adhesion molecules in atherosclerosis patients.

Authors:  Amir Hooshang Mohammadpour; Homa Falsoleiman; Jamal Shamsara; Ghazaleh Allah Abadi; Ramin Rasooli; Mohammad Ramezani
Journal:  Iran Biomed J       Date:  2014
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.